NanJing Pharmaceutical Co Ltd
SSE:600713
NanJing Pharmaceutical Co Ltd
Gross Profit
NanJing Pharmaceutical Co Ltd
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
NanJing Pharmaceutical Co Ltd
SSE:600713
|
Gross Profit
¥3.2B
|
CAGR 3-Years
8%
|
CAGR 5-Years
9%
|
CAGR 10-Years
10%
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Gross Profit
¥48.5B
|
CAGR 3-Years
6%
|
CAGR 5-Years
9%
|
CAGR 10-Years
14%
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Gross Profit
¥30B
|
CAGR 3-Years
3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
11%
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Gross Profit
¥11.4B
|
CAGR 3-Years
4%
|
CAGR 5-Years
9%
|
CAGR 10-Years
17%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Gross Profit
¥3.9B
|
CAGR 3-Years
7%
|
CAGR 5-Years
3%
|
CAGR 10-Years
18%
|
Huadong Medicine Co Ltd
SZSE:000963
|
Gross Profit
¥12.9B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
14%
|
See Also
What is NanJing Pharmaceutical Co Ltd's Gross Profit?
Gross Profit
3.2B
CNY
Based on the financial report for Mar 31, 2024, NanJing Pharmaceutical Co Ltd's Gross Profit amounts to 3.2B CNY.
What is NanJing Pharmaceutical Co Ltd's Gross Profit growth rate?
Gross Profit CAGR 10Y
10%
Over the last year, the Gross Profit growth was 0%. The average annual Gross Profit growth rates for NanJing Pharmaceutical Co Ltd have been 8% over the past three years , 9% over the past five years , and 10% over the past ten years .